Delaware District Court
Judge:Gregory B Williams
Case #: 1:25-cv-00372
Nature of Suit835 Property Rights - Patent – Abbreviated New Drug Application
Cause35:1 Patent Infringement
Case Filed:Mar 26, 2025
Last checked: Wednesday Mar 26, 2025 4:07 PM EDT
Defendant
Apotex Corp.
Defendant
Apotex Inc.
Plaintiff
Sumitomo Pharma America, Inc.
Represented By
Jennifer Ying
Morris, Nichols, Arsht & Tunnell LLP
contact info
Karen Jacobs
Morris, Nichols, Arsht & Tunnell LLP
contact info
Rodger Dallery Smith, II
Morris, Nichols, Arsht & Tunnell LLP
contact info
Lucinda Cole Cucuzzella
Morris, Nichols, Arsht & Tunnell LLP
contact info
Plaintiff
Urovant Sciences GmbH
Represented By
Jennifer Ying
Morris, Nichols, Arsht & Tunnell LLP
contact info
Karen Jacobs
Morris, Nichols, Arsht & Tunnell LLP
contact info
Rodger Dallery Smith, II
Morris, Nichols, Arsht & Tunnell LLP
contact info
Lucinda Cole Cucuzzella
Morris, Nichols, Arsht & Tunnell LLP
contact info


Docket last updated: 6 hours ago
Wednesday, April 09, 2025
8 8 service Waiver of Service Executed - 60 day ddl Wed 04/09 3:38 PM
WAIVER OF SERVICE returned executed by Sumitomo Pharma America, Inc., Urovant Sciences GmbH: For Apotex Corp. waiver sent on 4/8/2025, answer due 6/9/2025. (Jacobs, Karen)
Related: [-]
7 7 service Waiver of Service Executed - 60 day ddl Wed 04/09 3:37 PM
WAIVER OF SERVICE returned executed by Sumitomo Pharma America, Inc., Urovant Sciences GmbH: For Apotex Inc. waiver sent on 4/8/2025, answer due 6/9/2025. (Jacobs, Karen)
Related: [-]
Wednesday, April 02, 2025
utility Case Assigned/Reassigned Wed 04/02 11:41 AM
Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. Associated Cases: 1:25-cv-00372-GBW, 1:25-cv-00373-GBW (rjb)
Related: [-]
Wednesday, March 26, 2025
6 6 service Summons Issued Wed 03/26 3:33 PM
Summons Issued as to Apotex Corp. on 3/26/2025; Apotex Inc. on 3/26/2025.(oam)
Related: [-]
Att: 1 Summons Issued
5 5 misc Disclosure Statement - Rule 7.1 Wed 03/26 3:27 PM
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sumitomo Pharma Switzerland GmbH, Other Affiliate Sumitomo Chemical Co., Ltd., Other Affiliate Sumitomo Pharma Co., Ltd. for Urovant Sciences GmbH; Corporate Parent Sumitomo Pharma Co., Ltd., Other Affiliate Sumitomo Chemical Co., Ltd. for Sumitomo Pharma America, Inc. filed by Sumitomo Pharma America, Inc., Urovant Sciences GmbH. (oam)
Related: [-]
4 4 misc Patent/Trademark Report to Commissioner of Patents Wed 03/26 3:14 PM
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 12,102,638 B2. (oam)
Related: [-]
3 3 misc ANDA Form Wed 03/26 3:13 PM
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/17/2025. Date of Expiration of Patent: 05/22/2040. Thirty Month Stay Deadline: 6/23/2028. (oam)
Related: [-]
2 2 misc Magistrate Consent Forms Wed 03/26 3:11 PM
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam)
Related: [-]
1 1 13 pgs cmp Complaint Wed 03/26 3:10 PM
COMPLAINT for PATENT INFRINGEMENT filed against Apotex Corp., Apotex Inc. ( Filing fee $ 405, receipt number ADEDC-4646558.) - filed by Sumitomo Pharma America, Inc., Urovant Sciences GmbH.(oam)
Related: [-]
Att: 1 Exhibit A-B,
Att: 2 Civil Cover Sheet